MedTrace Logo

Effects of Vitamin B12 Treatment in Singers

NCT03437824 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-04-09

No results posted yet for this study

Summary

In this study, the investigators aim to assess if vitamin B12 treatment demonstrates a beneficial effect on voice performance. If so, they wish to examine the relationship between the vitamin B12 treatment and the study participant's general well-being.

Conditions

  • Vitamin B 12 Deficiency

Interventions

DRUG

Cyanocobalamin

1,000 mg, Once

DRUG

Placebo

0.9% Sodium Chloride, Once

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Principal Investigators

  • Hagit Shoffel-Havakuk, MD · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2019-04-01
Completion
2019-04-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03437824 on ClinicalTrials.gov